Jan Claassen, MD, FNCS
0 reviews
|
14 views
Business Details
Accessibility
Wheelchair accessible entrance
Wheelchair accessible restroom
Amenities
Restroom
Planning
Appointments recommended
Payments
Credit cards
Debit cards
About
Jan Claassen, MD, FNCS: Expert Neurocritical Care in Manhattan
Jan Claassen, MD, FNCS, represents a distinguished presence in the field of neurocritical care, offering specialized medical expertise to patients facing life-threatening neurological conditions in the heart of Manhattan, New York City. As a medical doctor (MD) and a Fellow of the Neurocritical Care Society (FNCS), Dr. Claassen possesses advanced training and certification specifically focused on the complex and critical care needs of individuals with severe brain and spinal cord injuries, strokes, seizures, and other acute neurological emergencies. This highly specialized discipline requires not only profound knowledge of neurology but also extensive experience in intensive care medicine, making professionals like Dr. Claassen uniquely qualified to manage the most challenging cases where timely and precise intervention is paramount for patient outcomes.
The practice associated with Dr. Claassen is dedicated to providing comprehensive, evidence-based care within the demanding environment of a neurological intensive care unit (neuro-ICU). Patients admitted to a neuro-ICU under the care of a specialist like Dr. Claassen often require continuous monitoring of brain function, intracranial pressure, and systemic physiology. Conditions treated can range from acute ischemic and hemorrhagic strokes, traumatic brain injuries, status epilepticus (prolonged seizures), severe infections affecting the brain and spinal cord, to complications following neurosurgery. The approach involves a multidisciplinary team, typically including neurologists, neurosurgeons, critical care nurses, respiratory therapists, pharmacists, and other specialists, all coordinated by the neurointensivist like Dr. Claassen to ensure integrated and optimal patient management.
Operating within the vibrant and medically advanced landscape of Manhattan, Dr. Claassen's work is crucial for the community, providing a vital resource for emergency neurological care. The FNCS designation signifies a commitment to the highest standards of practice and ongoing education in neurocritical care, reflecting a dedication to staying at the forefront of research and clinical advancements in this rapidly evolving field. This level of expertise is essential for navigating the complexities of neurological emergencies, where subtle changes in a patient's condition can have significant implications. The ability to interpret advanced neuroimaging, manage complex physiological support, and implement targeted therapies are hallmarks of a neurointensivist's skill set.
For patients and families facing the uncertainty of a critical neurological illness, having access to a highly qualified neurocritical care specialist in a major metropolitan area like NYC is invaluable. Dr. Claassen's practice focuses on delivering compassionate care while employing the most current diagnostic and therapeutic strategies to stabilize patients, prevent secondary brain injury, and optimize the potential for recovery. The environment of a neuro-ICU is intense, requiring constant vigilance and rapid decision-making, skills honed through years of dedicated training and experience in critical care neurology. The presence of a professional with the credentials of MD and FNCS in Manhattan underscores the availability of world-class medical expertise for the most critical neurological conditions in the region. [1] [2]
AUTHORITATIVE SOURCES
Information regarding the specialization of Neurocritical Care and the role of an MD, FNCS. [Neurocritical Care Society]↩
General information about medical specializations and critical care practice in major urban centers like New York City. [Columbia University Irving Medical Center]↩
Technical Info
Machine ID
/g/1wb8vmlb
Feature ID
0x89c2f69beda44e81:0x6b8ebcd1089b3e6
Created
14 Jan 2025
Updated
06 Jul 2026